Our special relationship with the doctor may affect our health. It is for this reason that we have created a classification that includes the five main types of patients: the “concerned”, the “know-it-all”, the “anti-doctor”, the “yes, doctor” or the “hedonist”.
We encourage you to detect which one of these profiles you most closely identify with, in order to be able to take your relationship with your doctor to a new level that is entirely satisfactory for both parties.
One of the problems that surgeons who currently operate on brain tumour patients have is the limited information available when making decisions about the different tissues in which the tumour appears. This is a limitation that also has implications in the possible side effects of the operation in the surrounding areas. What is relevant in these cases is that the damage to these brain tissues can lead to problems in the patient’s movements or their ability to speak.
Fortunately, it seems that in the not too distant future these decisions may be made simpler for surgeons. According to recent research published in the publication Proceedings of the National Academy of Science, the mass spectrometer could provide more information than is currently available in such highly complex operations.
In the words of Sandro Santagata of Brigham and Women's Hospital in Boston: "Thanks to this new approach, we are much closer to obtaining a comprehensive view of this problem during the actual surgical operation."
At present, a surgeon must wait at least 30 minutes to get the result of a biopsy or Read more
According to recent research, it seems that it is possible, as a new type of blood test could indicate whether the disease will appear within one year with a degree of accuracy of 87%.
This is, without a doubt, a major discovery made by King’s College London and Oxford University, along with other research centres, in this great mission for the scientific community – the early detection of Alzheimer’s.
According to the team of researchers involved, a blood test could identify as many as 10 proteins whose presence would determine with an accuracy rate of almost 90% whether patients with mild cognitive impairment will develop Alzheimer's over the following 12 months.
Extensive research offers encouraging results
To carry out this study, blood samples from 1,148 people were taken, of which 474 had already been diagnosed with Alzheimer's. The test results showed that 220 individuals had mild cognitive impairment, while 452 were elderly people without dementia.
In the first analysis, up to 26 proteins that could be considered indicators of the disease were Read more